Nitric oxide enhancement of melphalan-induced cytotoxicity

British Journal of Cancer

Volumn 76, Issue 3, 1997, Pages 325-334

  Cook, J A ^a   Krishna, M C ^a   Pacelli, R ^a   DeGraff, W ^a   Liebmann, J ^b   Mitchell, J B ^a   Russo, A ^a   Wink, D A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; MELPHALAN; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL STRAIN MCF 7; CELL STRAIN V 79; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; DRUG UPTAKE; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL;

EID: 0030872132     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.386     Document Type: Article

References (36)

1. Asano K, Chee CBE, Gaston B, Lilly CM, Gerard C, Drazen JM and Stamler JS (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91: 10089-10093
2. Calabresi P and Parks RE (1985) Antiproliferative agents and drugs used for immunosuppression. In The Pharmacological Basis of Therapeutics, Gilman AG, Goodman LS, Rall TW and Murad F (eds), pp. 1247-1306. Macmillan: New York
3. Canada A, Herman L, Kidd K, Robertson C and Trump D (1993) Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. Cancer Chemother Pharmacol 32: 73-77
4. Christodoulou D, Kudo S, Cook JA, Krishna MC, Miles A, Grisham MB, Murugesan R, Ford PC and Wink DA (1996) Electrochemical methods for the detection of nitric oxide. Methods Enzymol 268: 69-83
5. Colvin M and Chahner BA (1990) Alkylating agents. In Cancer Chemotherapy: Principles and Practice, Chabner BA and Collins JM (eds) pp. 276-313. JB Lippincott: Philadelphia
6. Cook JA, Iype SN and Mitchell JB (1991) Differential specificity of monochlorobimane for isozymes of human and rodent glutathione-S-transferases. Cancer Res 51: 1606-1612
7. Cook JA, Kim SA, Krishna MC, Pacelli R, Mitchell JB, Vodovotz Y, Nims RW, Christodoulou D, Miles AM, Grisham MB and Wink DA (1996) Convenient colorimetric and fluorimetric assays for S-nitrosothiols. Anal Biochem 238: 150-158
8. Fast DJ, Lynch RC and Leu RW (1992) Nitric oxide production by tumor targets in response to TNF: paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J Leukoc Biol 52: 255-261
9. Fienstein DL, Galea E, Roberts S, Berquist H, Wang H and Reis DJ (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 62: 315-321
10. Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM and Ozols RF (1984) Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res 44: 5427-5431
11. Hamilton TC, Winker MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC and Ozols RF (1985) Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian cancer cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 34: 2583-2586
12. Hibbs JB, Vavrin Z and Taintor RR (1987) L-arginine is required for the expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550-565
13. Kramer RA, Greene K, Ahmad S and Vistica DT (1987) Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Cancer Res 47: 1593-1597
14. Kroncke K-D, Fechsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, Bettermann H, Breunig KD and Kolb-Bachofen V (1994) Nitric oxide destroys zinc-finger clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 200: 1105-1110
15. Laval F and Wink DA (1994) Inhibition by nitric oxide of the repair protein O-methylguanine-DNA-methyltransferase. Carcinogenesis 15: 443-447
16. Lepoivre M, Boudbid H and Petit J-F (1994) Antiproliferative activity of interferon combined with lipopolysaccharide on murine adenocarcinoma: Dependence on an L-arginine metabolism with production of nitrite and nitrate. Cancer Res 49: 1970-1976
17. Liebmann J, Deluca AM, Coffin D, Keefer LK, Venzon D, Wink DA and Mitchell JB (1994) In vivo radiation protection by nitric oxide modulation. Cancer Res 54: 3365-3368
18. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Issac L, Hrabie JA and Keefer LK (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34: 3242-3247
19. Meyn RE and Murray D (1986) Cell cycle effects of alkylating agents. In Cell Cycle Effects of Drugs, Dethlefsen LA (ed.), pp. 170-188. Pergamon Press: New York
20. Misra RR, Hochadel JF, Smith GT, Waalkes MP and Wink DA (1995) Evidence that nitric oxide enhances cadmium toxicity by displacing the metals from metallothionein. Chem Res Toxicol 9: 326-332
21. Mitchell JB, Wink DA, Degralf W, Gamson J, Keefer LK and Krishna MC (1993) Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res 53: 5845-5848
22. O'Dwyer PJ, Hamilton TC, Lacreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL and Ozols RF (1996) Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol 14: 249-256
23. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D and Hamilton TC (1987) Enhanced melphalan toxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharm 36: 147-153
24. Robbins RA, Barnes BJ, Springall DR, Warren JB, Kwon OJ, Buttery LDK, Wilson AJ, Geiler DA and Polak JM (1994) Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 203: 209-218
25. Russo A, Tochner Z, Phillips T, Carmichael J, Degraff W, Friedman N, Fisher J and Mitchell JB (1986) In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan. Int J Radiat Oncol Biol Phys 12: 1187-1189
26. Saville B (1958) A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83: 670-672
27. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR and Pitt BR (1995) Metallothionein protects against the cytotoxic and DNA-dumaging effects of nitric oxide. Proc Natl Acad Sci USA 9: 4452-4456
28. Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD and Friedman HS (1988) Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Res 48: 2764-2767
29. Stuehr DJ and Nathan CF (1989) A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555
30. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V and Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1357
31. Walker MW, Kinter MT, Roberts RJ and Spitz DR (1995) Nitric oxide-induced cytotoxicity: Involvement of cellular resistance to oxidative stress and the role of glutathione in protection. Pediat Res 37: 41-47
32. Wink DA, Hanbauer I, Krishna MC, Degraff W, Gamson J and Mitchell JB (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90: 9813-9817
33. Wink DA and Laval J (1994) The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 15: 2125-2129
34. 2 reaction. Chem Res Toxicol 7: 519-525
35. Wink DA, Christodoulou D, Ho M, Krishna MC, Cook JA, Haul H, Randolph JK, Sullivan M, Coia G. Murray R and Meyer T (1995a) A discussion of electrochemical techniques for the detection of nitric oxide. Methods: A Companion to Methods in Enzymology, 7: 71-77
36. Wink DA, Cook JA, Krishna MC, Hanbauer I, Degraff W, Gamson J and Mitchell JB (1995b) Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: Further insights into the role nitric oxide plays in oxidative stress. Arch Biochem Biophys 319: 402-407